MoneyWorks4Me

Nutraplus India informs about board meeting

15 Oct 2024 Evaluate

Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘Listing Regulations’), Nutraplus India has informed that a meeting of the Board of Directors of the Company is scheduled to be held on Friday, October 18, 2024, to consider and approve the unaudited financial results of the Company for the quarter ended June 30, 2022. Pursuant to Company's ‘Code of Conduct to Regulate, Monitor and Report Trading by designated persons in securities of the Company’ under SEBI (Prohibition of Insider Trading) Regulations, 2015, the Trading Window for dealing in securities of the Company shall remain closed from October 15, 2024 till 48 hours from the announcement of the financial results of the Company for the quarter ended June 30, 2022.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..